| Abstrakt: |
A patent application titled "Controlled Lesion And Immune Response To Pulsed Electric Field Therapy" by Galvanize Therapeutics Inc. aims to treat abnormal tissue, particularly cancer, by directing pulsed electric field energy to create lesions that elicit an increase in adaptive immune response. The system includes energy delivery bodies and algorithms to generate specific zones within the lesion, potentially improving cancer treatment outcomes. The patent application outlines detailed methods and parameters for treating target tissue and tumors unresponsive to traditional therapies, emphasizing the potential synergistic effects when combined with immune checkpoint inhibitors. [Extracted from the article] |
